Consolidation hyperthermic intraperitoneal chemotherapy using paclitaxel in patients with epithelial ovarian cancer
Author:
Publisher
Wiley
Subject
Oncology,General Medicine,Surgery
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1002/jso.21448/fullpdf
Reference31 articles.
1. Global cancer statistics, 2002;Parkin;CA Cancer J Clin,2005
2. Survival benefits with diverse chemotherapy regimens for ovarian cancer: Meta-analysis of multiple treatments;Kyrgiou;J Natl Cancer Inst,2006
3. Secondary cytoreduction for patients with recurrent ovarian cancer;Diaz-Montes;Curr Oncol Rep,2005
4. Consolidation and maintenance treatments for patients with advanced epithelial ovarian cancer in complete response after first-line chemotherapy: A review of the literature;Gadducci;Crit Rev Oncol Hematol,2005
5. Intraperitoneal cisplatin plus intravenous cyclophosphamide versus intravenous cisplatin plus intravenous cyclophosphamide for stage III ovarian cancer;Alberts;N Engl J Med,1996
Cited by 58 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. The impact of Paclitaxel-based hyperthermic intraperitoneal chemotherapy in advanced high-grade serous ovarian cancer patients - interim analysis of safety and immediate efficacy of a randomized control trial (C-HOC trial);Journal of Ovarian Research;2024-07-12
2. Hyperthermia for Targeting Cancer and Cancer Stem Cells: Insights from Novel Cellular and Clinical Approaches;Stem Cell Reviews and Reports;2024-05-25
3. The 2022 PSOGI International Consensus on HIPEC Regimens for Peritoneal Malignancies: Epithelial Ovarian Cancer;Annals of Surgical Oncology;2023-08-10
4. Cancer-specific cytotoxicity of Ringer’s acetate solution irradiated by cold atmospheric pressure plasma;Free Radical Research;2023-02-01
5. Ten-year treatment outcomes of consolidation hyperthermic intraperitoneal chemotherapy for ovarian cancer (HIPEC-KOV-03R);Journal of Gynecologic Oncology;2023
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3